Genpact Limited (NYSE:G) recently announced tender offer to purchase up to $300m of common shares, which represent 7.5% of the market cap. Shares are expected to be purchased at $18 vs $17.1 current price. The tender offer will end on 2 April, providing current buyers with 5% return in two weeks or 130% annualized with no downside risk.
This idea might be more relevant for smaller investors as for holders of less than 100 shares, the share purchase is guaranteed. At the same time, I believe it is quite likely that the total number of shares tendered will be below the $300m, and thus pro rata adjustments to tendering shareholders might not be applicable, making it a guaranteed...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|